Article Details

DiaMedica Therapeutics (NASDAQ:DMAC) Issues Earnings Results, Beats Estimates By $0.07 EPS

Retrieved on: 2022-05-07 16:25:00

Tags for this article:

Click the tags to see associated articles and topics

DiaMedica Therapeutics (NASDAQ:DMAC) Issues Earnings Results, Beats Estimates By $0.07 EPS. View article details on hiswai:

Excerpt

Two Sigma Investments LP acquired a new stake in shares of DiaMedica Therapeutics in the third quarter worth $298,000. Finally, State Street Corp ...

Article found on: www.defenseworld.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up